Blueshift Asset Management, LLC Amneal Pharmaceuticals, Inc. Transaction History

Blueshift Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$4.31 - $5.64 $102,315 - $133,887	-23,739 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$5.12 - $6.82 $81,576 - $108,663	-15,933 Reduced 40.16%	23,739 $122,000
Q1 2021 May 06, 2021	BUY	$4.74 - $7.38 $188,045 - $292,779	39,672 New	39,672 $267,000
Q1 2020 May 14, 2020	SELL	$2.46 - $5.35 $163,747 - $356,117	-66,564 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.65 - $5.56 $45,829 - $96,154	17,294 Added 35.1%	66,564 $321,000
Q3 2019 Nov 12, 2019	BUY	$2.29 - $7.1 $112,828 - $349,817	49,270 New	49,270 $143,000

185

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.25B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.